IPOInitial public offering — registration (F-1)
- Sector
- Healthcare
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Exchange
- Nasdaq
- State of incorporation
- E9
- Form
- F-1
- Filed
- March 18, 2022
Filings & documents
Every entry traces to SEC EDGAR. The Information Statement is the primary source; the links below open the full filing and each company's complete filing history.
Source filing ↗F-1 · the filing we parseAll documents in this filing ↗accession 0001213900-22-013563Virax Biolabs Group Ltd — all SEC filings ↗EDGAR company page
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.